Phase I Trial of Cetuximab, Radiotherapy, & Ipilimumab in Locally Advanced Head & Neck Cancer
Concomitant radiotherapy with cetuximab, an anti-EGFR mAb, is a common treatment for locally...
Read MoreMay 3, 2022
Concomitant radiotherapy with cetuximab, an anti-EGFR mAb, is a common treatment for locally...
Read MoreMay 3, 2022
In this study, the objective was to evaluate whether perioperative anti-HER2 therapy retarded cell...
Read MoreMay 3, 2022
DNA methyltransferase inhibitors are frequently used to treat patients with acute myeloid leukemia...
Read MoreMay 3, 2022
In three Phase I/II trials, Eransertinib potently blocked TRKA/B/C and ROS1, resulting in deep...
Read MoreMay 3, 2022
To report on the first-in-human phase I study of VIP152 (NCT02635672), a highly selective and...
Read MoreMay 3, 2022
For a study, researchers sought to have the addition of ixazomib to lenalidomide maintenance...
Read MoreMay 3, 2022
The goal of this research is to assess ponatinib in patients with advanced gastrointestinal...
Read MoreMay 3, 2022
Endocrine resistance arising from HER2mutions (HER2mut) has been observed in estrogen...
Read MoreMay 3, 2022
Vismodegib is indicated for locally advanced basal cell carcinoma (la BBC), although some...
Read MoreMay 3, 2022
Patients with uncommon malignancies (incidence less than 6 cases per 100,000 persons per year) are...
Read MoreMay 3, 2022
MONDAY, May 2, 2022 (HealthDay News) — State affirmative action bans are associated with a...
Read MoreMay 2, 2022
MONDAY, May 2, 2022 (HealthDay News) — Artificial intelligence cuts the miss rate of...
Read MoreMay 2, 2022
MONDAY, May 2, 2022 (HealthDay News) — An artificial intelligence tool can analyze computed...
Read MoreMay 2, 2022
Brain metastases from ovarian cancer remain rare and the appropriate treatment is unknown. We...
Read MoreMay 2, 2022
Ovarian clear cell carcinoma (OCCC) is one of the most lethal types of ovarian cancer. Early-stage...
Read MoreApr 29, 2022
FRIDAY, April 29, 2022 (HealthDay News) — Black patients are less likely to receive proton...
Read MoreApr 29, 2022
FRIDAY, April 29, 2022 (HealthDay News) — Compared with heterosexual students, sexual...
Read MoreApr 29, 2022
Chemotherapy can have a variety of adverse consequences, including chemotherapy-induced cognitive...
Read MoreApr 29, 2022
Open surgery has become the standard technique for radical hysterectomy (International Federation...
Read MoreApr 29, 2022
1. Neoadjuvant nivolumab plus chemotherapy led to a longer event-free survival and higher...
Read More